The Future of Self-Care Regulation in Europe: Maximising Innovation
This article was originally published in SRA
Executive Summary
Hubertus Cranz of industry association AESGP describes how regulations for non-prescription medicines must change.
You may also be interested in...
The EMA at 20: An increasing impact on the non-prescription medicines market
The EU regulatory system has brought some positive results in the area of non-prescription medicines, but further progress is needed to meet the expectations of the self-care sector, says Hubertus Cranz.
The EMA at 20: An increasing impact on the non-prescription medicines market
The EU regulatory system has brought some positive results in the area of non-prescription medicines, but further progress is needed to meet the expectations of the self-care sector, says Hubertus Cranz.